Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date

Stephanie Si,1,2 David T Teachey1,2 1Children’s Hospital of Philadelphia, Division of Oncology, Philadelphia, PA, USA; 2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USACorrespondence: Stephanie SiUniversity of Hawai’i Cancer...

Full description

Bibliographic Details
Main Authors: Si S, Teachey DT
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Therapeutics and Clinical Risk Management
Subjects:
chimeric antigen receptor t-cell therapy
cytokine release syndrome
tocilizumab
pediatric
Online Access:https://www.dovepress.com/spotlight-on-tocilizumab-in-the-treatment-of-car-t-cell-induced-cytoki-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/spotlight-on-tocilizumab-in-the-treatment-of-car-t-cell-induced-cytoki-peer-reviewed-article-TCRM

Similar Items